HIV-1 Low-Level Viremia Predicts Viral Failure in Participants on Antiretroviral Therapy in the Swiss HIV Cohort Study
LLV was strongly associated with risk of subsequent viral failure, even after adjustment for demographic and clinical characteristics, including adherence and treatment regimen. The detection of LLV should prompt appropriate measures to decrease the risk of subsequent viral failure.
Authors
- PHILIP E. TARR (ORCID: https://orcid.org/0000-0002-1488-5407)
- M Egger
- Luigia Elzi (ORCID: https://orcid.org/0009-0002-7676-8756)
- Enos Bernasconi (ORCID: https://orcid.org/0000-0002-9724-8373)
- Dunja Nicca (ORCID: https://orcid.org/0000-0002-4133-8177)
- Niklaus Daniel Labhardt (ORCID: https://orcid.org/0000-0003-3599-1791)
- Matthias L. Cavassini (ORCID: https://orcid.org/0000-0003-0933-7833)
- Olivia Keiser (ORCID: https://orcid.org/0000-0001-8191-2789)
- Angela Ciuffi (ORCID: https://orcid.org/0000-0003-2333-513X)
- G Dollenmaier
- Caroline Lanz (ORCID: https://orcid.org/0000-0002-6250-8550)
- J.H. Meier (ORCID: https://orcid.org/0000-0001-7044-8300)
- Hans Hellmuth Hirsch (ORCID: https://orcid.org/0000-0003-0883-0423)
- Johannes Nemeth (ORCID: https://orcid.org/0000-0003-0683-456X)
- Karoline Aebi‐Popp (ORCID: https://orcid.org/0000-0002-9337-900X)
- Maja Weisser (ORCID: https://orcid.org/0000-0002-0134-1929)
- Gilles Wandeler (ORCID: https://orcid.org/0000-0002-5278-8763)
- Irène A. Abela (ORCID: https://orcid.org/0000-0002-5566-8628)
- Helen Kovari (ORCID: https://orcid.org/0000-0003-4896-4231)
- David Jackson‐Perry (ORCID: https://orcid.org/0000-0001-5889-1553)
- Anna Hachfeld (ORCID: https://orcid.org/0000-0001-9308-7130)
- Begoña Martínez de Tejada (ORCID: https://orcid.org/0000-0001-5737-3586)
- Matthieu Perreau (ORCID: https://orcid.org/0000-0003-2110-2244)
- Barbara Hasse (ORCID: https://orcid.org/0000-0001-7196-3734)
- Catia Marzolini (ORCID: https://orcid.org/0000-0002-2312-7050)
- P Paioni
- Luisa Salazar‐Vizcaya (ORCID: https://orcid.org/0000-0003-0527-0141)
- Thomas Klimkait (ORCID: https://orcid.org/0000-0003-4945-6511)
- Marcel Stoeckle (ORCID: https://orcid.org/0000-0002-0088-5078)
- D Haerry
- Alexandra Calmy
- Huldrych F. Günthard (ORCID: https://orcid.org/0000-0002-1142-6723)
- Alexandra Trkola (ORCID: https://orcid.org/0000-0003-1013-876X)
- Christian R. Kahlert (ORCID: https://orcid.org/0000-0002-0784-3276)
- Michael Huber (ORCID: https://orcid.org/0000-0002-0384-0000)
- Karoline Leuzinger (ORCID: https://orcid.org/0000-0002-5654-9356)
- Roger D. Kouyos (ORCID: https://orcid.org/0000-0002-9220-8348)
- Hansjakob Furrer (ORCID: https://orcid.org/0000-0002-1375-3146)
- Michael Stöckle
- Roberto F. Speck (ORCID: https://orcid.org/0000-0002-8453-1137)
- G Pantaleo (ORCID: https://orcid.org/0009-0000-7192-8664)
- Julia Notter (ORCID: https://orcid.org/0000-0003-4821-9995)
- Tom Loosli (ORCID: https://orcid.org/0000-0003-2049-3562)
- Olivier Ségéral (ORCID: https://orcid.org/0000-0002-3996-8663)
- Katharina Kusejko (ORCID: https://orcid.org/0000-0002-4638-1940)
- Dominique L. Braun (ORCID: https://orcid.org/0000-0003-4036-1030)
- Andri Rauch (ORCID: https://orcid.org/0000-0001-5297-6062)
- Jacques Fellay (ORCID: https://orcid.org/0000-0002-8240-939X)
- A Anagnostopoulos (ORCID: https://orcid.org/0000-0001-6197-3023)
- N Müller (ORCID: https://orcid.org/0000-0002-0303-7322)
- Patrick Schmid (ORCID: https://orcid.org/0000-0003-1978-5082)
- K J Metzner
- Christoph A. Fux
- M Battegay
- H C Bucher
- Irène Hösli
- Matthew Hoffmann
- S Yerly
Institutions
- University of Geneva (CH)
- University of Bern (CH)
- University of Basel (CH)
- University of Zurich (CH)
- University of St.Gallen (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Ente Ospedaliero Cantonale (CH)
- University Hospital of Zurich (CH)
- University Hospital of Geneva (CH)
- Office of Infectious Diseases (US)
- Geneva College (US)
- University of Lausanne (CH)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1093/cid/ciae569
- Citations
- 8
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.35
Funders
- National Science Foundation
- Bill and Melinda Gates Foundation
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Gilead Sciences
- ViiV Healthcare
- Moderna
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
- National Institutes of Health